Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $25.70 Consensus Price Target from Brokerages
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned an average rating of “Hold” from the eleven ratings firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have assigned a buy recommendation to the […]
7 Sep 05:58 · The Markets Daily